Literature DB >> 29092013

LAG-3: another brake to release in breast cancer?

M Kok1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29092013     DOI： 10.1093/annonc/mdx708

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy.

Authors:  Sebastian Chrétien; Ioannis Zerdes; Jonas Bergh; Alexios Matikas; Theodoros Foukakis
Journal:  Cancers (Basel)       Date:  2019-05-05       Impact factor: 6.639

Review 2.  The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review.

Authors:  Yu Liu; Peixin Chen; Hao Wang; Shengyu Wu; Sha Zhao; Yayi He; Caicun Zhou; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2021-02

3.  LAG3 and its emerging role in cancer immunotherapy.

Authors:  Miao Wang; Qi Du; Jiangtao Jin; Yuhan Wei; Yuting Lu; Qin Li
Journal:  Clin Transl Med       Date:  2021-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.